BlackRock Will Join The S&P 500 index, And Replace Genzyme Tonight

Share This Article
April 1, 2011 3:49pm NYSE:IVE NYSE:IVV

After the close of trading on Friday BlackRock Inc (NYSE:BLK). will replace Genzyme Corp (NASDAQ:GENZ). in the S&P 500 index (SNP:^GSPC). S&P is making the change because biotech company Genzyme announced last month that it would be taken private for $20.1 billion by


 France’s Sanofi-Aventis SA.

Barrons.com is quoting Citi’s William Katz as saying, “He’s estimating that inclusion in the S&P 500 will translate into roughly 10.5 million shares needed by index buyers against average daily trading volume of 840,000 shares over the the past three months.”

The addition of a company to a widely-followed index has historically given shares a boost, but this impact has been magnified significantly in recent years with the rise in popularity of passively-indexed ETFs that generally strive to track the movements of an underlying index within a few basis points.

Due to the addition and deletion of the two funds, ETFs like iShares S&P 500 Index (NYSE:IVV), Vanguard S&P 500 ETF (NYSE:VOO) and SPDR S&P 500 (NYSE:SPY) will now have to go out into the market and complete trades to achieve the requires find composition.


9 "Must Own" Growth Stocks For 2019

Read Next



Get Free Updates

Join over 50,000 investors who get the latest news from ETFDailyNews.com!

Most Popular



Explore More from ETFDailyNews.com

Free Daily Newsletter

Get daily ETF insights from our market experts. Never miss another important market development again!

ETFDailyNews.com respects your privacy.

Best ETFs

We've rated and ranked nearly 2,000 ETFs and ETNs using our proprietary SMART Grade system.

View Top Rated ETFs

Best Categories

We've ranked dozens of ETF categories based on relative performance.

Best ETF Categories